Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
02/2006
02/16/2006WO2006015851A1 Piperazine derivatives with ccr3 inhibiting activity
02/16/2006WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists
02/16/2006WO2004112729A3 Dual function compounds and uses thereof
02/16/2006US20060035940 (S)-Amlodipine malate
02/16/2006US20060035938 2-Pyridone derivatives as inhibitors of neutrophile elastase
02/16/2006US20060035935 Acylated piperidine derivatives as melanocortin-4 receptor agonists
02/16/2006US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase
02/16/2006DE102004034682A1 Verkürztes Verfahren zur Herstellung von chiralem Lobelin Shortened process for the preparation of chiral lobeline
02/16/2006CA2575039A1 Novel cyclic amino benzoic acid derivative
02/16/2006CA2574292A1 Piperazine derivatives with ccr3 inhibiting activity
02/16/2006CA2572845A1 Formation of tetra-substituted enamides and stereoselective reduction thereof
02/15/2006EP1626044A1 Novel piperidine derivative
02/15/2006EP1626043A1 Heterocyclic thioesters
02/15/2006EP1625114A1 Chemical compounds
02/15/2006EP1008346B1 NF-kB INHIBITORS CONTAINING BENZOQUINONE DERIVATIVES
02/15/2006CN1735597A 2-piperidone derivatives as prostaglandin agonists
02/15/2006CN1735596A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
02/15/2006CN1735595A Substituted alkyl amido piperidines
02/15/2006CN1735592A Hydroxyethylamine derivatives for the treatment of alzheimer's disease
02/15/2006CN1733728A Novel donepezil synthesis process
02/15/2006CN1733707A Compounds and methods for synthesis and therapy
02/15/2006CN1241916C Novel acardite compound, its preparation method and medicinal composition containing said compound
02/15/2006CN1241901C Perfluoronated cycle-containing tertiary amines used as basis for gas-conveying emulsions and preparation method
02/14/2006US6998488 Which are the melanocortin-4 receptor agonists;halogenating the benzonitrile or benzoic acid or benzamide; Grignard; arylation of the pyridinium; hydrogenation; 4-phenylpiperidine-1-carboxcylic acid esthers
02/14/2006US6998487 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties
02/14/2006US6998405 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
02/14/2006US6998401 Such as 2-(4-amino-2,3,5-trimethylphenoxy)-N-methyl-N-(4-piperidinyl)acetamide which has neuroprotective effects by inducing calcium binding proteins
02/14/2006US6998115 Biodegradable and biocompatible and may be used in a variety of drug delivery systems; suited for the delivery of polynucleotides
02/14/2006CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists
02/14/2006CA2363145C Oxamic acids and derivatives as thyroid receptor ligands
02/14/2006CA2263167C Ether muscarinic antagonists
02/14/2006CA2210044C 4-hydroxy-piperidine derivatives
02/14/2006CA2209825C Heterocyclic-fused pyridines
02/14/2006CA2105666C New centrally acting substituted phenylazacycloalkanes
02/09/2006WO2006014136A1 Piperidine derivatives as histamine h3 receptor ligands
02/09/2006WO2006014134A1 Novel piperidine derivative for the treatment of depression
02/09/2006WO2006014012A2 Aromatic compounds
02/09/2006US20060030602 (S)-amlodipine malate
02/09/2006US20060030599 Sulphonamide derivatives
02/09/2006US20060030587 Method of treating attention deficit disorders with d-threo methylphenidate
02/09/2006US20060030585 N-(2-[9-(8-Azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthen-3-yl]-phenyl)-acetamide; veterinary medicine; side effect reduction; analgesics; antagonist; antiinflammatory agents; psychhological/nervous system/urogenital disorders; drug abuse; diarrhea; gastritis; cardiovascular/respiratory disorders; kits
02/09/2006US20060030558 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds
02/09/2006US20060030553 Cell adhesion inhibitors
02/09/2006DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments
02/09/2006DE19812066B4 Katalytisches System The catalytic system
02/09/2006CA2576112A1 Piperidine derivatives as histamine h3 receptor ligands
02/09/2006CA2576073A1 Novel piperidine derivative for the treatment of depression
02/09/2006CA2573223A1 Aromatic compound
02/08/2006EP1622871A1 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them
02/08/2006EP1622868A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
02/08/2006EP1318978B1 N-acylsulfonamide apoptosis promoters
02/08/2006EP1235776B1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
02/08/2006EP1131289B1 Processes for preparing 2-piperidineethanol compounds
02/08/2006CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives
02/08/2006CN1732153A Novel piperidine derivatives as modulators of chemokine receptor CCR5
02/08/2006CN1730476A Aromatic amine ketone compounds, its synthesis method, pharmaceutical composition containing same and uses
02/08/2006CN1730475A Aromatic amine ketene compounds, its synthesis method, pharmaceutical composition containing same and uses
02/08/2006CN1240699C Remedies or preventives for diseases in association with chemokines
02/07/2006US6995270 Hydrogenation process
02/07/2006US6995269 Guanidinobenzamides
02/07/2006US6995268 Heterocyclic amines such as 4-(2-(diphenylmethoxy)ethyl)-1-((3-fluorophenyl)methyl)piperidine, used for prophylaxis nervous system disorders, drug abuse and dependence, Parkinson's disease or as antidepressants
02/07/2006US6995224 Isoprene-styrene copolymer, butadiene-styrene copolymer or butadiene-isoprene-styrene terpolymer randomly modified from 1-5%, e.g., of an p-(2-pyrrolidinoisopropyl-)styrene; tire tread; filler receptivity; low hysterises; rolling resistance;
02/07/2006US6995180 for the treatment of diabetes, hyperglycemia, hypoglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis, eating disorders, and nervous system disorders
02/07/2006US6995179 N-type calcium channel blockers, antiischemic agents
02/07/2006US6995172 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
02/07/2006US6995142 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
02/07/2006CA2360308C Glucocorticoid receptor modulators
02/07/2006CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors
02/02/2006WO2006012256A2 Fkbp binding composition and pharmaceutical use thereof
02/02/2006WO2006012227A2 Amido compounds and their use as pharmaceuticals
02/02/2006WO2006012226A2 N-substituted piperidines and their use as pharmaceuticals
02/02/2006WO2006012173A1 Amido compounds and their use as pharmaceuticals
02/02/2006WO2006011669A1 Novel cinnamic acid related compounds
02/02/2006WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor
02/02/2006WO2006011154A1 A novel polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride) and a process for producing thereof
02/02/2006WO2006010968A1 New aryloxy acetic acid amide derivatives
02/02/2006WO2006010966A1 New benzoyl urea derivatives
02/02/2006WO2006010577A1 Substituted 3-phenylpiperidine derivatives
02/02/2006WO2006010422A1 Guanidine derivatives and therapeutic uses thereof
02/02/2006US20060025596 Method for deuteration or tritiation of heterocyclic ring
02/02/2006US20060025459 Having Asp2 ( beta -secretase, BACE1 or Memapsin) inhibitory activity, for therapy of diseases characterised by elevated beta -amyloid levels or beta -amyloid deposits
02/02/2006US20060025455 New 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes
02/02/2006US20060025446 Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders
02/02/2006US20060025444 Fexofenadine base polymorphic forms
02/02/2006US20060025443 3(3-methoxyphenyl)-3-(3-dimethylaminopropyl)-4,4-dimethylpiperidine-2,6-dione pamoate; serotonin receptor antagonist; antidepressant, anxiolytic agent; migraine and sleep apnoea; weight loss and hepatocyte changes
02/02/2006US20060025442 Acylated piperidine derivatives as melanocortin-4 receptor agonists
02/02/2006US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/02/2006US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
02/02/2006US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
02/02/2006CA2574947A1 Guanidine derivatives and therapeutic uses thereof
02/02/2006CA2574158A1 New benzoyl urea derivatives
02/02/2006CA2570903A1 N-hydroxyamide derivatives and use thereof
02/02/2006CA2570694A1 Amido compounds and their use as pharmaceuticals
02/02/2006CA2569507A1 Amido compounds and their use as pharmaceuticals
02/01/2006EP1621532A1 Fexofenadine base polymorphic forms
02/01/2006EP1620432A1 Nk-2 antagonist basic linear compounds and formulations containing them
02/01/2006EP1620403A1 Novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives
02/01/2006EP1620402A1 Cyclic quaternary amino derivatives as modulators of chemokine receptors
02/01/2006EP1620401A2 Phenyl substituted cyclic derivatives
02/01/2006EP1620400A1 Chemical compounds